title: [Hairy cell leukemia: Part II: therapy with cladribine].
abstract: The purine analogue cladribine is a highly active cytotoxic drug for the treatment of hairy cell leukemia. The substance is easy to use and patient friendly. After preparation of a special, sophisticated formulation by a pharmaceutical cytotoxic lab, the patient might even apply the drug himself. This review points out the potential of this non-patented pharmaceutical, besides practical advices.
authors.affiliation: Medizinische Klinik und Poliklinik IV des Universitätsklinikums Giessen, Klinikstrasse 36, 35385 Giessen. Juergen.Barth@innere.med.uni-giessen.de
authors.forename: Jürgen
authors.initials: J
authors.lastname: Barth
authors.forename: Mathias J
authors.initials: MJ
authors.lastname: Rummel
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007943:Leukemia, Hairy Cell / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D017338:Cladribine